サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1756487

院内感染対策の世界市場：種類別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)

Hospital Acquired Infection Control Market, By Type, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 388 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.58円
院内感染対策の世界市場：種類別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2024年～2032年)
出版日: 2025年05月15日
発行: AnalystView Market Insights
ページ情報: 英文 388 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

院内感染対策の市場規模は2024年に213億4,598万米ドルとなり、2024年から2032年にかけてCAGR 6.80％で拡大

院内感染対策の市場力学

院内感染（HAI）に対する意識の高まり

院内感染（医療関連感染）のリスクと結果に対する意識の高まりは、HAI対策市場の重要な促進要因です。医療専門家、管理者、患者は、入院期間の長期化、医療費の増加、死亡率の上昇など、HAIがもたらす危険についてより多くの情報を得るようになっています。このような意識の高まりにより、医療施設は感染対策を優先し、高度な予防技術に投資するようになっています。WHOやCDCを含む世界中の規制機関や保健機関は、厳しいガイドラインを発表し、HAIのサーベイランスと管理の重要性をさらに強調しています。これを受けて、病院は抗菌剤表面、滅菌装置、デジタル追跡システムの使用など、強固な感染予防プロトコルを導入しています。さらに、公衆衛生キャンペーンやメディア報道が一般住民を啓蒙し、安全性に対する患者の期待が高まっています。その結果、感染対策ソリューションに対する需要は、先進国市場と新興国市場の両方で拡大しています。

院内感染対策市場：主な考察

当社のリサーチアナリストによると、世界の院内感染対策市場は、2024年から2032年にかけて約6.80%のCAGRで発展すると予測されています。

種類別では、2023年に機器カテゴリが市場を独占しています。

最終用途別では、病院と集中治療室（ICU）が2023年に最も多くの収入を生み出しました。

地域別では、2023年に北米が最も収益を上げた地域でした。

院内感染対策市場：セグメンテーション分析

世界の院内感染対策市場は、種類、最終用途、地域の3つに分類されます。

院内感染（HAI）対策市場は、種類別に装置、サービス、消耗品に区分されます。装置には、無菌の医療環境を維持するために不可欠な滅菌装置、消毒システム、空気清浄機などが含まれます。サービスには、専門のプロバイダーが提供する感染サーベイランス、トレーニング、コンプライアンス管理などが含まれます。消毒薬、防腐剤、手袋、ガウン、マスクなどの消耗品は、感染の拡大を防ぐために毎日使用されます。UV-Cシステム、自動滅菌器、HEPAろ過などの高度な消毒技術への投資が増加していることから、機器類が市場を独占することになりそうです。病院や医療施設は、特にICUや手術室のようなリスクの高いエリアにおいて、一貫した感染予防を保証する耐久性のあるインフラを優先しています。長期的な感染対策ソリューションと国際的な安全基準への準拠を求める動きが、最先端機器の採用を加速させています。医療システムの近代化に伴い、包括的な感染制御戦略において重要な役割を果たす機器は、市場シェアをリードしていくと予想されます。

院内感染（HAI）対策市場は、最終用途別に病院・集中治療室（ICU）、外来手術・診断センター、長期ケア施設や診療所を含むその他に分類されます。病院とICUは、患者の入院が多く、医療処置が複雑で、感染伝播のリスクが高いことから、市場を独占すると予測されます。特にICUは、免疫不全患者、侵襲的器具、長期入院を扱うため、HAIのホットスポットとなっています。その結果、このような病棟では厳格な感染制御プロトコルが必要とされ、設備、消耗品、専門サービスへの継続的な投資が必要となります。病院全体の衛生基準の実施、政府の規制、認定要件が、このセグメントの需要をさらに押し上げています。さらに、HAIの世界の増加や関連する医療費の削減の必要性から、病院やICUは感染制御ソリューションの主要な消費者となっています。

院内感染対策市場：地域別分析

地域的には、院内感染対策市場は北米、アジア太平洋、ラテンアメリカ、欧州、中東・アフリカに分布しています。これらの地域は、ビジネスをもたらしている国に基づいてさらに分割されます。

北米は院内感染（HAI）対策市場において支配的な地域であり、高度な医療インフラ、厳格な政府規制、感染対策に対する意識の高まりがその原動力となっています。大規模な医療システムを有し、院内感染の有病率が上昇している米国が、この地域で最大の市場シェアを占めています。米国疾病予防管理センター（CDC）やその他の規制機関が厳格な感染対策を実施しているため、病院や医療提供者は機器や消耗品、サービスに多額の投資を行うようになっています。さらに、自動滅菌システムや空気清浄ユニットなどの先端技術の採用率が高いことも、市場の成長をさらに後押ししています。カナダも重要な役割を果たしており、公衆衛生キャンペーンや医療の近代化を通じて感染予防の強化に注力しています。

欧州もHAIコントロール市場の主要地域のひとつであり、強力な医療制度と患者の安全重視がその原動力となっています。欧州連合（EU）は、感染予防の改善と院内感染の発生率低減を目的とした規制を導入し、市場の成長を促進しています。ドイツ、英国、フランスなどの国々は、医療のインフラが確立されており、UV殺菌や抗菌表面コーティングなどの高度な感染制御技術の導入が進んでいます。この地域は高い医療水準の維持を重視しており、効果的な感染制御ソリューションに対する認識と需要の高まりと相まって、欧州を市場の主要企業として位置付けています。その他の特典として、欧州市場は医療提供者と感染制御ソリューションサプライヤー間の強力な協力関係により、ベストプラクティスの普及が保証されています。

院内感染対策市場：競合情勢

院内感染（HAI）対策市場の競合力学は、先進技術に注力する既存企業と新規参入企業が混在して形成されています。3M社、Belimed Inc.社、Getinge社、STERIS社などの大手企業は、滅菌システム、消毒剤、個人防護具（PPE）などの包括的な感染制御ソリューションで市場を独占しています。これらの企業は、製品の品質、規制遵守、製品機能強化のための強固な研究開発努力を重視していることで知られています。また、感染監視と追跡を改善するため、デジタルヘルス・ソリューションにも多額の投資を行っています。さらに、W&H社やMidmark Corporation社などの新規参入企業やイノベーターは、安全性と効率性を向上させるために先進的な滅菌装置や自動化システムを導入しています。例えば、市場の主要企業であるステリジェニクス社は、ガンマ線滅菌技術に注力し、滅菌能力を世界に拡大しています。このような競合環境がイノベーションを促進し、感染制御プロトコルの改善を促し、医療提供者と患者の転帰に利益をもたらしています。

目次

第1章 院内感染対策市場の概要

  • 分析範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 院内感染対策の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 院内感染対策市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 院内感染対策市場：新型コロナウイルス感染症 (COVID-19) の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 院内感染対策の市場情勢

  • 院内感染対策の市場シェア分析 (2023年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 院内感染対策市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • 装置
      • 滅菌装置
      • 加熱滅菌装置
      • 低温滅菌
      • 放射線滅菌
      • 消毒装置
      • 洗濯機消毒器
      • フラッシャー消毒器
      • 内視鏡再処理装置システム
    • サービス
    • 消耗品
      • 消毒剤
      • 滅菌消耗品

第8章 院内感染対策市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院・集中治療室（ICU）
    • 外来手術・診断センター
    • その他

第9章 院内感染対策市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：院内感染対策業界

  • 競合ダッシュボード
  • 企業プロファイル
    • 3M
    • Belimed Inc.
    • O&M Halyards
    • Getinge
    • ASP（Advanced Sterilization Products Services, Inc.）
    • Sterigenics US, LLC-A Sotera Health Company
    • MMM Group
    • Midmark Corporation
    • STERIS
    • W&H
    • Others

第11章 AnalystViewの全方位的分析

目次
Product Code: ANV5295

REPORT HIGHLIGHT

Hospital Acquired Infection Control Market size was valued at USD 21,345.98 Million in 2024, expanding at a CAGR of 6.80% from 2024 to 2032.

Hospital Acquired Infection (HAI) Control refers to the comprehensive strategies and practices implemented within healthcare facilities to prevent, monitor, and manage infections that patients acquire during their stay in a hospital or clinical setting. These infections typically develop 48 hours or more after admission and are not present or incubating at the time of entry. Effective HAI control involves a combination of strict hygiene protocols, sterilization of medical instruments, appropriate use of personal protective equipment (PPE), antimicrobial stewardship, and staff training. Surveillance systems are also essential to detect outbreaks and track infection trends. Key infections targeted include bloodstream infections, urinary tract infections, pneumonia, and surgical site infections. The aim is to protect both patients and healthcare workers, minimize complications, reduce healthcare costs, and improve patient outcomes. Continuous education, adherence to guidelines such as those from the CDC or WHO, and institutional commitment are critical to ensuring successful infection control in hospitals.

Hospital Acquired Infection Control Market- Market Dynamics

Rising Awareness of Hospital-Acquired Infections (HAIs)

Increasing awareness about the risks and consequences of hospital-acquired infections is a significant driver of the HAI control market. Healthcare professionals, administrators, and patients are becoming more informed about the dangers posed by HAIs, such as prolonged hospital stays, increased healthcare costs, and higher mortality rates. This growing awareness has prompted healthcare facilities to prioritize infection control measures and invest in advanced prevention technologies. Regulatory bodies and health organizations worldwide, including the WHO and CDC, have issued stringent guidelines, further emphasizing the importance of HAI surveillance and control. In response, hospitals are adopting robust infection prevention protocols, including the use of antimicrobial surfaces, sterilization equipment, and digital tracking systems. Additionally, public health campaigns and media coverage have educated the general population, leading to greater patient expectations for safety. As a result, the demand for infection control solutions is expanding across both developed and emerging markets.

HOSPITAL ACQUIRED INFECTION CONTROL Market- Key Insights

According to our research analyst, the global Hospital Acquired Infection Control Market is expected to develop at a CAGR of approximately 6.80% between 2024-2032.

Segmented by Type in 2023, the Equipment category dominated the market.

Based on End Use segmentation, the Hospitals and Intensive Care Units (ICUs) generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Hospital Acquired Infection Control Market- Segmentation Analysis:

The global Hospital Acquired Infection Control market is divided into three categories: type, end use and region.

The Hospital Acquired Infection (HAI) Control market is segmented by type into Equipment, Services, and Consumables. Equipment includes sterilization devices, disinfection systems, and air purification units essential for maintaining a sterile healthcare environment. Services encompass infection surveillance, training, and compliance management offered by specialized providers. Consumables such as disinfectants, antiseptics, gloves, gowns, and masks are used daily to prevent the spread of infections. Equipment is set to dominate the market, driven by increasing investments in advanced disinfection technologies such as UV-C systems, automated sterilizers, and HEPA filtration. Hospitals and healthcare facilities are prioritizing durable infrastructure that ensures consistent infection prevention, especially in high-risk areas like ICUs and operating rooms. The push for long-term infection control solutions and compliance with international safety standards is accelerating the adoption of cutting-edge equipment. As healthcare systems modernize, equipment is expected to lead in market share due to its critical role in comprehensive infection control strategies.

The Hospital Acquired Infection (HAI) Control market is categorized by end-use into Hospitals and Intensive Care Units (ICUs), Ambulatory Surgical and Diagnostic Centres, and Others, which include long-term care facilities and clinics. Hospitals and ICUs are projected to dominate the market due to the high volume of patient admissions, complex medical procedures, and increased risk of infection transmission in these settings. ICUs, in particular, deal with immunocompromised patients, invasive devices, and extended hospital stays, making them hotspots for HAIs. As a result, these units require strict infection control protocols and continuous investment in equipment, consumables, and specialized services. The implementation of hospital-wide hygiene standards, government regulations, and accreditation requirements further drives demand in this segment. Moreover, the rising global burden of HAIs and the need to reduce associated healthcare costs make hospitals and ICUs the leading consumers of infection control solutions.

Hospital Acquired Infection Control Market- Geographical Insights

Geographically, the Hospital Acquired Infection Control Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Hospital Acquired Infection (HAI) Control market, driven by advanced healthcare infrastructure, stringent government regulations, and increasing awareness about infection control. The United States, with its large healthcare system and rising prevalence of healthcare-associated infections, holds the largest market share in the region. The Centers for Disease Control and Prevention (CDC) and other regulatory bodies enforce strict infection control measures, encouraging hospitals and healthcare providers to invest heavily in equipment, consumables, and services. Additionally, the high adoption rate of advanced technologies, such as automated sterilization systems and air purification units, further boosts market growth. Canada also plays a significant role, focusing on enhancing infection prevention through public health campaigns and healthcare modernization.

Europe is another dominant region in the HAI Control market, driven by a strong healthcare system and a focus on patient safety. The European Union has introduced regulations aimed at improving infection prevention and reducing the incidence of hospital-acquired infections, fostering market growth. Countries like Germany, the UK, and France have well-established healthcare infrastructures and are increasingly adopting advanced infection control technologies, such as UV sterilization and antimicrobial surface coatings. The region's emphasis on maintaining high healthcare standards, combined with rising awareness and demand for effective infection control solutions, positions Europe as a key player in the market. Additionally, the European market benefits from strong collaborations between healthcare providers and infection control solution suppliers, ensuring widespread adoption of best practices.

Hospital Acquired Infection Control Market- Competitive Landscape:

The competitive dynamics of the Hospital Acquired Infection (HAI) Control market are shaped by a mix of established players and new entrants focusing on advanced technologies. Major companies like 3M, Belimed Inc., Getinge, and STERIS dominate the market with a comprehensive range of infection control solutions, including sterilization systems, disinfectants, and personal protective equipment (PPE). These companies are known for their emphasis on product quality, regulatory compliance, and robust R&D efforts to enhance product features. They also make significant investments in digital health solutions to improve infection surveillance and tracking. Additionally, new entrants and innovators, such as W&H and Midmark Corporation, are introducing advanced sterilization equipment and automation systems to improve safety and efficiency. For instance, Sterigenics, a key player in the market, focuses on gamma sterilization technology and expanding its sterilization capabilities globally. This competitive environment fosters innovation and drives improvements in infection control protocols, benefiting healthcare providers and patient outcomes.s

Recent Developments:

In September 2023, 3M launched the Clean-Coat Surface Protectant, a coating designed to eliminate up to 99.9% of bacteria and viruses on high-touch surfaces in hospitals. This innovation aims to reduce the risk of cross-contamination in healthcare environments.

In October 2023, Getinge expanded its sterilization capabilities by acquiring Healthmark Industries Co., Inc., strengthening its position in the U.S. infection control market and enhancing its offerings for instrument sterilization and compliance.

In March 2024, W&H introduced the eLog system, a digital logbook that automatically records and saves sterilization cycles and routine tests. This system enhances workflow efficiency while ensuring compliance with sterilization documentation requirements.

In July 2024, Midmark Corporation unveiled its next-generation M11 and M9 steam sterilizers, featuring enhanced durability and integrated capabilities to streamline instrument processing and improve compliance documentation efficiency.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M
  • Belimed Inc.
  • O&M Halyards
  • Getinge
  • ASP (Advanced Sterilization Products Services, Inc.)
  • Sterigenics U.S., LLC - A Sotera Health Company
  • MMM Group
  • Midmark Corporation
  • STERIS
  • W&H
  • Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Equipment
  • Sterilization Equipment
  • Heat Sterilization Equipment
  • Low Temperature Sterilization
  • Radiation Sterilization
  • Disinfection Equipment
  • Washer Disinfector
  • Flusher Disinfector
  • Endoscopic Reprocessor Systems
  • Services
  • Consumables
  • Disinfectants
  • Sterilization Consumables

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY END USE - MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Intensive Care Units (ICUs)
  • Ambulatory Surgical and Diagnostic Centres
  • Others

GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hospital Acquired Infection Control Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hospital Acquired Infection Control Market Snippet by Type
    • 2.1.2. Hospital Acquired Infection Control Market Snippet by End-Use
    • 2.1.3. Hospital Acquired Infection Control Market Snippet by Country
    • 2.1.4. Hospital Acquired Infection Control Market Snippet by Region
  • 2.2. Competitive Insights

3. Hospital Acquired Infection Control Key Market Trends

  • 3.1. Hospital Acquired Infection Control Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hospital Acquired Infection Control Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hospital Acquired Infection Control Market Opportunities
  • 3.4. Hospital Acquired Infection Control Market Future Trends

4. Hospital Acquired Infection Control Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hospital Acquired Infection Control Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hospital Acquired Infection Control Market Landscape

  • 6.1. Hospital Acquired Infection Control Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hospital Acquired Infection Control Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Equipment
      • 7.1.2.1. Sterilization Equipment
      • 7.1.2.1.1. Heat Sterilization Equipment
      • 7.1.2.1.2. Low Temperature Sterilization
      • 7.1.2.1.3. Radiation Sterilization
      • 7.1.2.2. Disinfection Equipment
      • 7.1.2.2.1. Washer Disinfector
      • 7.1.2.2.2. Flusher Disinfector
      • 7.1.2.2.3. Endoscopic Reprocessor Systems
    • 7.1.3. Services
    • 7.1.4. Consumables
      • 7.1.4.1. Disinfectants
      • 7.1.4.2. Sterilization Consumables

8. Hospital Acquired Infection Control Market - By End-Use

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By End-Use, 2023 & 2032 (%)
    • 8.1.2. Hospitals and Intensive Care Units (ICUs)
    • 8.1.3. Ambulatory Surgical and Diagnostic Centres
    • 8.1.4. Others

9. Hospital Acquired Infection Control Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hospital Acquired Infection Control Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hospital Acquired Infection Control Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hospital Acquired Infection Control Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hospital Acquired Infection Control Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hospital Acquired Infection Control Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By End-Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hospital Acquired Infection Control Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. 3M
    • 10.2.2. Belimed Inc.
    • 10.2.3. O&M Halyards
    • 10.2.4. Getinge
    • 10.2.5. ASP (Advanced Sterilization Products Services, Inc.)
    • 10.2.6. Sterigenics U.S., LLC - A Sotera Health Company
    • 10.2.7. MMM Group
    • 10.2.8. Midmark Corporation
    • 10.2.9. STERIS
    • 10.2.10. W&H
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us